A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties

John Busby; Liam Murray; Ken Mills; Shu-Dong Zhang; Fabio Liberante; Chris R. Cardwell

doi:10.1002/pds.4345

A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties

John Busby
, Liam Murray
, Ken Mills
, Shu-Dong Zhang
, Fabio Liberante
, Chris R. Cardwell

Cancer Research UK

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Original language	English
Pages (from-to)	78-86
Journal	Pharmacoepidemiology and Drug Safety
Volume	27
Issue number	1
DOIs	https://doi.org/10.1002/pds.4345
Publication status	Published (in print/issue) - 4 Dec 2017

Keywords

breast cancer
connectivity mapping
drug discovery
pharmacoepidemiology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/pds.4345

Cite this

@article{8d90f815daf94169bb950c2fce123c2c,

title = "A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties",

keywords = "breast cancer, connectivity mapping, drug discovery, pharmacoepidemiology",

author = "John Busby and Liam Murray and Ken Mills and Shu-Dong Zhang and Fabio Liberante and Cardwell, \{Chris R.\}",

year = "2017",

month = dec,

day = "4",

doi = "10.1002/pds.4345",

language = "English",

volume = "27",

pages = "78--86",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1099-1557",

publisher = "John Wiley and Sons Ltd",

number = "1",

}

TY - JOUR

T1 - A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties

AU - Busby, John

AU - Murray, Liam

AU - Mills, Ken

AU - Zhang, Shu-Dong

AU - Liberante, Fabio

AU - Cardwell, Chris R.

PY - 2017/12/4

Y1 - 2017/12/4

KW - breast cancer

KW - connectivity mapping

KW - drug discovery

KW - pharmacoepidemiology

U2 - 10.1002/pds.4345

DO - 10.1002/pds.4345

M3 - Article

C2 - 29205633

SN - 1099-1557

VL - 27

SP - 78

EP - 86

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - 1

ER -